/Amcor%20Plc%20logo%20on%20building%20by-%20jetcityimage%20via%20iStock.jpg)
Zurich, Switzerland-based Amcor plc (AMCR) is a global leader in developing and producing responsible packaging solutions across a diverse range of materials for the food, beverage, pharmaceutical, and personal care industries. It is valued at a market cap of $18.4 billion.
Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Amcor fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the packaging & containers industry. The company operates a massive global footprint spanning over 40 countries, with a core specialty in high-barrier flexible packaging and recycle-ready rigid containers.
This packaging company has slipped 23.9% from its 52-week high of $50.94, reached on Feb. 24. Shares of AMCR have declined 4.9% over the past three months, outperforming the Nasdaq Composite’s ($NASX) 5.5% drop during the same time frame.
However, on a YTD basis, shares of Amcor are down 5.5%, slightly lagging NASX’s 5.3% fall. Moreover, in the longer term, AMCR has fallen 19.9% over the past 52 weeks, notably trailing NASX’s 24% uptick over the same time frame.
To confirm its bearish trend, AMCR has been trading below its 200-day and 50-day moving averages since early March.
On Feb. 3, Amcor delivered mixed Q2 results, and its shares surged 8.1% in the subsequent trading session. Mainly due to the Berry acquisition, the company’s net sales increased 68.1% year-over-year to $5.4 billion, yet missed analyst expectations by 1.8%. Nonetheless, on the upside, its adjusted EPS of $0.86 grew 7.5% from the year-ago quarter and topped consensus estimates of $0.83, bolstering investor confidence.
AMCR has notably lagged its rival, Sealed Air Corporation (SEE), which gained 40.2% over the past 52 weeks and increased marginally on a YTD basis.
Looking at AMCR’s recent outperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of "Moderate Buy” from the 16 analysts covering it, and the mean price target of $52.19 suggests a 35.2% premium to its current price levels.
